Paroxetine CR
Paroxetine CR is a pharmaceutical drug with 10 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.5%
7 of 8 finished
12.5%
1 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms
Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
Major Depressive Disorder Study In Adults
Depression Study In Elderly Patients
Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients
Clinical Trials (10)
Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms
Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
Major Depressive Disorder Study In Adults
Depression Study In Elderly Patients
Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients
Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome
Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)
A Local Register Study For Major Depression Of Paroxetine Controlled Release
Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence
Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10